Results 251 to 260 of about 264,729 (304)

Siglec-engaging immunosuppressive sialoglycans are upregulated in prostate cancer and are targetable to suppress bone metastasis

open access: yes
Peng Z   +17 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Nanomaterials for bone metastasis

Journal of Controlled Release
Bone metastasis, a prevalent occurrence in primary malignant tumors, is often associated with a grim prognosis. The bone microenvironment comprises various coexisting cell types, working together in a coordinated manner. This dynamic microenvironment plays a pivotal role in the initiation and progression of bone metastases.
Zhihong Li, Shasha He, Zhaoqi Li
exaly   +3 more sources

miRNAs in bone metastasis

open access: yesExpert Review of Endocrinology & Metabolism, 2017
Bone metastasis is one of the most common forms of metastasis from a number of different primary carcinomas. MicroRNAs (miRNAs) are short, endogenous RNAs that negatively regulate gene expression to control essential pathways, including those involved in bone organogenesis and homeostasis. As these pathways are often hijacked during bone metastasis, it
Cheung, DG, Buzzetti, M, Di Leva, G
openaire   +3 more sources

Pathology of Bone Metastasis

open access: yes, 2018
Bone metastases are a frequent complication of advanced cancer. Interactions between cancer cells and marrow stromal cells and bone turnover mechanisms are crucial in metastases growth and the pathogenesis of bone damage. Metastatic tumour cells stimulate the bone remodelling and indirectly induce the osteocytes to release several growth factors that ...
Carlo della Rocca, Claudio Di Cristofano
openaire   +3 more sources

Home - About - Disclaimer - Privacy